Epidemiology and characteristics of febrile neutropenia in oncology patients from Spanish tertiary care hospitals: PINNACLE study.

about

Epidemiology and characteristics of febrile neutropenia in oncology patients from Spanish tertiary care hospitals: PINNACLE study.

Item

http://www.wikidata.org/entity/Q35753638

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Epidemiology and characteristi ...... are hospitals: PINNACLE study.

@ast

Epidemiology and characteristi ...... are hospitals: PINNACLE study.

@en

type

Item

label

Epidemiology and characteristi ...... are hospitals: PINNACLE study.

@ast

Epidemiology and characteristi ...... are hospitals: PINNACLE study.

@en

prefLabel

Epidemiology and characteristi ...... are hospitals: PINNACLE study.

@ast

Epidemiology and characteristi ...... are hospitals: PINNACLE study.

@en

P1476

Epidemiology and characteristi ...... are hospitals: PINNACLE study.

@en

P2093

Agustí Barnadas-Molins

http://www.w3.org/2001/XMLSchema#string

Ana Maria Casas-Fernández-DE Tejerina

http://www.w3.org/2001/XMLSchema#string

Antonio Antón-Torres

http://www.w3.org/2001/XMLSchema#string

Bartomeu Massuti-Sureda

http://www.w3.org/2001/XMLSchema#string

Carlos Camps-Herrero

http://www.w3.org/2001/XMLSchema#string

Enrique Aranda-Aguilar

http://www.w3.org/2001/XMLSchema#string

Francisco José Rebollo Laserna

http://www.w3.org/2001/XMLSchema#string

Javier DE Castro Carpeño

http://www.w3.org/2001/XMLSchema#string

Juan Jesús Cruz-Hernández

http://www.w3.org/2001/XMLSchema#string

Pere Gascón-Vilaplana

http://www.w3.org/2001/XMLSchema#string

P2860

Granulocyte colony-stimulating factor in the treatment of high-risk febrile neutropenia: a multicenter randomized trial.

Chemotherapy dose reduction and delay in clinical practice. evaluating the risk to patient outcome in adjuvant chemotherapy for breast cancer.

Dose reductions and delays: limitations of myelosuppressive chemotherapy.

30 years' follow up of randomised studies of adjuvant CMF in operable breast cancer: cohort study

The Multinational Association for Supportive Care in Cancer risk index: A multinational scoring system for identifying low-risk febrile neutropenic cancer patients.

2002 guidelines for the use of antimicrobial agents in neutropenic patients with cancer.

Antimicrobial prophylaxis and outpatient management of fever and neutropenia in adults treated for malignancy: American Society of Clinical Oncology clinical practice guideline.

2006 update of recommendations for the use of white blood cell growth factors: an evidence-based clinical practice guideline.

Colony-stimulating factors for chemotherapy-induced febrile neutropenia: a meta-analysis of randomized controlled trials.

Mortality, morbidity, and cost associated with febrile neutropenia in adult cancer patients.

P304

725-729

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3892/MCO.2015.524

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2015-03-05T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

279728994

http://www.w3.org/2001/XMLSchema#string

P698

26137294

http://www.w3.org/2001/XMLSchema#string

P932

4471542

http://www.w3.org/2001/XMLSchema#string